Elsubrutinib,Upadacitinib,ABBV-599
AbbVie
['elsubrutinib', ' upa ', ' ofa ', 'upadacitinib', 'lupus', 'abbv-599']
#eular2023 #op0139 should we aim for dual blockade in #lupus? a phase 2 rct showed more patients on abbv-599 hd (elsubrutinib (btk-i) + upadacitinib (jak-i)) and upa monotherapy met primary &amp; secondary endpoints vs placebo at 48wks. no major malignancy or vte concerns 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏